THURSDAY, July 25, 2024 (HealthDay News) — Obese kids infected with dengue are significantly more likely to suffer severe illness requiring hospitalization, a new study warns. A new analysis of nearly 5,000 dengue-infected Sri Lankan children found that weight plays a powerful role in how sick the mosquito-borne virus canContinue Reading
TUESDAY, July 23, 2024 (HealthDay News) — The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat type 2 diabetes, a new study finds. New prescriptions for these drugs have doubled among people who haveContinue Reading
TUESDAY, July 23, 2024 (HealthDay News) — Consistently bad sleep is linked to a person’s risk of developing type 2 diabetes, a new study shows. Both too little and too much sleep is tied to diabetes risk, and swinging wildly between the two patterns of poor sleep reflects the mostContinue Reading
FRIDAY, July 19, 2024 (HealthDay News) — Pudgy with a purpose: Fat cats could help humans better understand the way gut bacteria influences conditions like obesity and type 2 diabetes, a new study claims. Food-related changes in obese cats’ gut microbiome have striking similarities to the way diet affects theContinue Reading
FRIDAY, July 12, 2024 (HealthDay News) — Nearly half of cancer deaths and 4 of 10 cases of cancer are linked to a person’s lifestyle, a new study says. Cigarette smoking remains the biggest cancer risk, contributing to 30% of cancer deaths and 20% of cancer cases, results show. ButContinue Reading
THURSDAY, July 11, 2024 (HealthDay News) — Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows. Conducted by Prime Therapeutics and Magellan Rx Management (MRx), the review sifted through pharmacy and medical claims data forContinue Reading
MONDAY, July 8, 2024 (HealthDay News) — Mounjaro outperforms Ozempic in helping people lose weight, a new study shows. People taking tirzepatide (Mounjaro, Zepbound) dropped significantly more pounds than those taking semaglutide (Ozempic, Wegovy), researchers reported July 8 in the journal JAMA Internal Medicine. “Individuals with overweight or obesity treatedContinue Reading
MONDAY, July 8, 2024 (HealthDay News) — In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help reduce the risk of some cancers. In a study published July 5 in JAMA Network Open, researchers found peopleContinue Reading
MONDAY, July 8, 2024 (HealthDay News) — Researchers have identified a gene that can trigger obesity, behavior problems and postpartum depression when missing or damaged. The finding could lead to new treatments for postpartum depression and overeating: The study in mice suggests the so-called “love hormone” — oxytocin — mayContinue Reading
WEDNESDAY, July 3, 2024 (HealthDay News) — Weight gain is a common side effect of antidepressants, but some types cause people to pack on pounds more than others, a new study says. Bupropion users are 15% to 20% less likely to gain a significant amount of weight than those takingContinue Reading
TUESDAY, July 2, 2024 (HealthDay News) — Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide had 50% to 56% decreased odds for either becoming alcoholic or relapsing into alcoholism, researchers reported recently in the journal Nature Communications. Few drugs areContinue Reading
FRIDAY, June 28, 2024 (HealthDay News) — Specific types of gut bacteria appear to be linked to compulsive eating, a new study reports. Researchers found that one type of gut bacteria — the Proteobacteria family — is abundant in people and mice with an addiction to food. Other types ofContinue Reading
WEDNESDAY, June 26, 2024 (HealthDay News) — Low-birth-weight newborns have a higher risk of health complications if they become obese as children, a new study has found. Obese children who were low-birth-weight babies have a higher risk of insulin resistance, fatty liver and other health problems, researchers found. The studyContinue Reading
TUESDAY, June 24, 2024 (HealthDay News) — Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows. Both men and women showed improved heart function after a year on semaglutide, the active ingredient in Ozempic and Wegovy, researchers report. Women tended to lose moreContinue Reading